WHO YOU ARE

You are a team-player with demonstrated ability to excel in a fast-paced, collaborative environment, who operates with independence but requires some guidance for complex projects. You must have expertise on the scientific, technical and competitive landscape(s) in the Neuroscience, Immunology and/or Rear Disease therapeutic areas, to develop scenarios and prosecution rationales, and to make thoughtful recommendations to senior management.

REQUIRED SKILLS

• PhD in the life sciences or related field (e.g. neuroscience drug discovery/development).
• Detailed understanding of the pharmaceutical drug discovery/development process, with 12+ years in pre-clinical development, clinical development, and/or search & evaluation experience.
• Track-record of experience in the Neuroscience, Immunology and/or Rear Disease therapeutic areas
• Expertise in Neuroscience, Immunology and/or Rear Disease therapeutic areas and multiple modalities.
• Broad knowledge of drug development and key disciplines (R&D).
• Comprehensive experience of cross functional project leadership
• Experience driving alignment with cross-functional stakeholders (e.g., Research, Development, Manufacturing, Medical, Regulatory, etc.) to bring sound evaluations and external opportunity recommendations forward to senior management
• Experience presenting proposals of notable risk and complexity to senior managementTravel about 3 to 4 times per year with one trip being international
• 
  Job Level: Management

ABOUT THIS ROLE

Corporate Development leads the establishment of Biogen’s corporate strategy and is responsible for the identification, assessment and negotiation of external opportunities to augment Biogen’s pipeline, as well as integration of acquired companies and management of relationships with Biogen’s partners.
The Search & Evaluation Director will be contributing to the search and evaluation process to proactively identify and scientifically/technically evaluate external growth opportunities for inbound partnering (e.g., collaborations, licensing, and M&A) in the Neuroscience, Immunology and/or Rear Disease therapeutic areas for Biogen with potential for growth.

WHAT YOU’LL DO

• Work closely with Corporate Strategy and R&D Leadership to clearly understand the external business strategy and search priorities within the therapeutic areas of Neuroscience, Immunology and/or Rear Disease.
• Proactively identify and scientifically/technically evaluate external growth opportunities for inbound partnering/acquisition in the Neuroscience, Immunology and/or Rear Disease therapeutic areas.
• Proactively survey the emerging scientific and technological competitive landscape in the Neuroscience, Immunology and/or Rear Disease therapeutic areas.
• Benchmark new opportunities and propose prioritization of opportunities within the Neuroscience, Immunology and/or Rear Disease therapeutic areas for further evaluation.
• Develop assessment, scenarios, prosecution rationales, and recommendations for external opportunities
• Lead focused cross-functional teams in the early evaluation of opportunities with focus on the scientific and technical merit to advance (or exclude) opportunities. Integrate data sets with an interdisciplinary perspective.
• Lead scientific and clinical cross-functional due diligence deal teams to advance external opportunities of notable risk and complexity to term sheet. Develop the strategy for project execution.
• Build key networks, both internally and externally, to survey proactively the emerging scientific and technological competitive landscape in Neuroscience, Immunology and/or Rear Disease therapeutic areas of strategic interest, including pre-clinical, near-clinical (pre-IND/CTA), and clinical development programs
• Scout new external opportunities by contributing to systematic screens, attending conferences, participating in scientific/clinical congresses, and maintaining a strong network in the scientific/clinical and the biotech/pharma/VC community
• Create written summaries of evaluations in the form of memos and visual presentations and leads the deal team into governance discussions with senior leadership that frame the scientific and strategic importance of proposed opportunities